AMLX Presents ALS Trial Data
Amylyx Pharmaceuticals presents data from first-in-human, dose-ranging Phase 1 LUMINA trial of AMX0114 in ALS at ENCALS 2026
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Amylyx Pharmaceuticals presents data from first-in-human, dose-ranging Phase 1 LUMINA trial of AMX0114 in ALS at ENCALS 2026